Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study
Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contra...
Saved in:
Published in | Allergy Vol. 64; no. 2; pp. 234 - 241 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.02.2009
Blackwell Publishing Ltd Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. |
---|---|
AbstractList | Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods: Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results: Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions: These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. [PUBLICATION ABSTRACT] Background:Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.Methods:Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.Results:Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.Conclusions:These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods: Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy‐one never‐exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results: Skin test specificity was 96–100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross‐reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions: These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods: Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy‐one never‐exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results: Skin test specificity was 96–100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross‐reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions: These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.BACKGROUNDIodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.METHODSSkin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.RESULTSSkin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.CONCLUSIONSThese data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. |
Author | Lerch, M Tomaz, E Barbaud, A Romano, A Faria, E Bonadonna, P Ring, J Demoly, P Bircher, A.J Brockow, K Pichler, W.J Aberer, W Christiansen, C Rodrigues Cernadas, J Kanny, G |
Author_xml | – sequence: 1 fullname: Brockow, K – sequence: 2 fullname: Romano, A – sequence: 3 fullname: Aberer, W – sequence: 4 fullname: Bircher, A.J – sequence: 5 fullname: Barbaud, A – sequence: 6 fullname: Bonadonna, P – sequence: 7 fullname: Faria, E – sequence: 8 fullname: Kanny, G – sequence: 9 fullname: Lerch, M – sequence: 10 fullname: Pichler, W.J – sequence: 11 fullname: Ring, J – sequence: 12 fullname: Rodrigues Cernadas, J – sequence: 13 fullname: Tomaz, E – sequence: 14 fullname: Demoly, P – sequence: 15 fullname: Christiansen, C |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21059512$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19178403$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1uEzEUhS1URNPCK4CFRHcT_Dcz9gKkqmoBKRKL0rXlce60DhM72B7avD0eErLoJnhjS_7Ote895wyd-OABIUzJnJb1cTWnXMlKKVXPGSFyTqjkbP70As0OFydoRiipK1FzeYrOUloRQlqmyCt0ShVtpSB8htLtT-dxhpSdv8fluDHZgc8JP7r8gB-2G4gJfHLZ_XZ5iyMYm13wCeeAXVg6bzIssQ0-R5MyXsPSGVxhg6_HGDZgPF6PQ3a21ISIUx6X29foZW-GBG_2-zm6u7n-cfW1Wnz_8u3qclHZuiGs4kL0qm87S82yk4JK2lrBgRtay6YDJZveAAcmOtmzDmSnClVDgSzjbSf5ObrY1d3E8GssLeq1SxaGwXgIY9JNIxtCa34UFA3lvGbkKMiIILStVQHfPwNXYYy-dKupaqQSVEzPvt1DY1fmpjfRrU3c6n_uFODDHjDJmqGPxluXDhwr9qqassJ93nE2hpQi9Nq6bCabiilu0JToKTZ6pad06CkdeoqN_hsb_VQKyGcFDn85Lv20kz66Abb_rdOXi8V0Kvp3O31vgjb3sfR3d8sI5cWZMgTV8j8UcONQ |
CODEN | LLRGDY |
CitedBy_id | crossref_primary_10_1016_S1877_0320_09_72483_2 crossref_primary_10_1016_S1959_5182_12_58698_8 crossref_primary_10_1111_j_1365_2133_2011_10623_x crossref_primary_10_1259_bjr_20220494 crossref_primary_10_1016_j_iac_2014_04_002 crossref_primary_10_1111_all_12589 crossref_primary_10_32902_2663_0338_2020_3_43_51 crossref_primary_10_1016_j_jpp_2019_07_004 crossref_primary_10_1186_s12948_020_00128_3 crossref_primary_10_3390_diagnostics14020123 crossref_primary_10_51620_0869_2084_2021_66_12_747_754 crossref_primary_10_1016_j_waojou_2021_100561 crossref_primary_10_1016_j_jaip_2020_12_057 crossref_primary_10_1016_j_jaip_2023_10_040 crossref_primary_10_3346_jkms_2015_30_3_245 crossref_primary_10_1016_j_anai_2017_08_014 crossref_primary_10_1007_s00108_008_2210_0 crossref_primary_10_1097_ACI_0000000000000282 crossref_primary_10_1016_j_crad_2010_11_006 crossref_primary_10_1111_all_12350 crossref_primary_10_1007_s00330_024_10872_8 crossref_primary_10_1177_1538574417736420 crossref_primary_10_3390_ijms241612577 crossref_primary_10_1016_j_iac_2014_04_013 crossref_primary_10_1111_all_14656 crossref_primary_10_1016_j_jaip_2022_12_048 crossref_primary_10_1016_j_iac_2021_12_001 crossref_primary_10_1016_j_jdcr_2020_08_006 crossref_primary_10_1097_ACI_0000000000001001 crossref_primary_10_1111_cod_14654 crossref_primary_10_1016_j_mcna_2010_03_007 crossref_primary_10_2214_AJR_19_21547 crossref_primary_10_1016_j_iac_2023_04_002 crossref_primary_10_1016_j_rx_2024_03_011 crossref_primary_10_1016_j_ancard_2012_09_007 crossref_primary_10_1016_j_annder_2010_01_005 crossref_primary_10_2174_1381612829666221025091827 crossref_primary_10_1016_j_iac_2009_04_003 crossref_primary_10_1016_j_iac_2009_04_001 crossref_primary_10_1016_j_reval_2017_05_002 crossref_primary_10_1007_s40521_019_00226_x crossref_primary_10_1016_j_iac_2009_04_008 crossref_primary_10_1016_j_heliyon_2021_e08401 crossref_primary_10_1016_j_anai_2013_01_004 crossref_primary_10_3348_kjr_2018_19_2_352 crossref_primary_10_1093_ced_llae294 crossref_primary_10_1016_j_jaip_2021_04_006 crossref_primary_10_1016_S0025_6196_11_60756_8 crossref_primary_10_1097_ACI_0000000000000285 crossref_primary_10_1111_j_1365_2222_2010_03487_x crossref_primary_10_1111_cod_13790 crossref_primary_10_1177_08465371241311253 crossref_primary_10_1016_j_jaip_2020_11_023 crossref_primary_10_2332_allergolint_12_LE_0455 crossref_primary_10_1016_j_legalmed_2016_11_006 crossref_primary_10_1148_radiol_222467 crossref_primary_10_1016_j_jaip_2019_04_036 crossref_primary_10_1016_j_jacr_2014_09_032 crossref_primary_10_1016_j_ejrad_2010_12_049 crossref_primary_10_1136_rapm_2019_100911 crossref_primary_10_3389_fphar_2016_00171 crossref_primary_10_1016_j_nefroe_2021_05_009 crossref_primary_10_3390_medicina58040517 crossref_primary_10_1007_s15007_017_1327_7 crossref_primary_10_1016_j_iac_2014_01_014 crossref_primary_10_1007_s40521_018_0154_8 crossref_primary_10_1016_j_mcna_2010_03_006 crossref_primary_10_1097_MOO_0b013e32833ad4c9 crossref_primary_10_1007_s40261_013_0055_3 crossref_primary_10_1016_j_annfar_2011_01_001 crossref_primary_10_1016_j_anai_2016_07_010 crossref_primary_10_1016_j_jaip_2019_04_005 crossref_primary_10_1177_0310057X1704500504 crossref_primary_10_4065_84_7_663_a crossref_primary_10_1016_j_iac_2022_01_003 crossref_primary_10_1016_j_reval_2016_01_040 crossref_primary_10_1111_j_1365_2222_2010_03693_x crossref_primary_10_2174_1574886316666210923143012 crossref_primary_10_1002_ccd_28618 crossref_primary_10_1016_j_ejrad_2021_110101 crossref_primary_10_1016_j_rxeng_2024_03_012 crossref_primary_10_1136_rapm_2018_000012 crossref_primary_10_1186_1710_1492_9_12 crossref_primary_10_36691_RJA551 crossref_primary_10_3390_biomedicines10051036 crossref_primary_10_1016_j_reval_2011_01_034 crossref_primary_10_1111_cod_14063 crossref_primary_10_1016_S0098_1672_09_79046_0 crossref_primary_10_4161_onci_26333 crossref_primary_10_1016_j_anai_2010_12_020 crossref_primary_10_1177_1538574418765386 crossref_primary_10_25259_JCIS_47_2024 crossref_primary_10_1007_s00105_013_2695_x crossref_primary_10_1371_journal_pone_0100154 crossref_primary_10_1016_j_jaip_2019_08_001 crossref_primary_10_1177_02841851251321476 crossref_primary_10_1055_a_1581_1663 crossref_primary_10_1111_j_1365_2222_2009_03425_x crossref_primary_10_1111_all_15433 crossref_primary_10_1007_s40521_019_00224_z crossref_primary_10_1097_ACI_0b013e3283312f84 crossref_primary_10_1097_ACI_0b013e32833e0896 crossref_primary_10_1016_j_jaci_2015_07_035 crossref_primary_10_1016_j_jaip_2024_10_039 crossref_primary_10_1586_ecp_10_32 crossref_primary_10_1111_all_12168 crossref_primary_10_1016_j_reval_2011_05_008 crossref_primary_10_1016_j_mayocp_2012_01_012 crossref_primary_10_4168_aard_2014_2_5_352 crossref_primary_10_4168_aard_2018_6_5_270 crossref_primary_10_1148_radiol_2019190829 crossref_primary_10_3233_JRS_230021 crossref_primary_10_1016_j_jaip_2020_01_014 crossref_primary_10_1097_ACI_0b013e32834877c3 crossref_primary_10_1016_j_jaci_2018_10_063 crossref_primary_10_1111_jdv_16139 crossref_primary_10_4168_aard_2016_4_6_442 crossref_primary_10_1080_00325481_2017_1282296 crossref_primary_10_23736_S0392_0488_20_06698_5 crossref_primary_10_4168_aard_2020_8_3_107 crossref_primary_10_1186_s12890_024_02993_z crossref_primary_10_1016_j_jaci_2011_05_034 crossref_primary_10_1248_bpb_b14_00346 crossref_primary_10_1007_s13341_014_0478_3 crossref_primary_10_1016_j_mcna_2010_04_003 crossref_primary_10_1016_j_jaip_2023_12_005 crossref_primary_10_12793_jkscpt_2012_20_2_165 crossref_primary_10_1002_pds_1650 crossref_primary_10_1111_all_12617 crossref_primary_10_1097_ACI_0000000000000411 crossref_primary_10_1111_j_1398_9995_2011_02554_x crossref_primary_10_1111_cod_13981 crossref_primary_10_1016_j_chemosphere_2017_11_154 crossref_primary_10_1080_23744235_2021_2009129 crossref_primary_10_1097_ACI_0b013e328362b926 crossref_primary_10_1016_j_ajo_2016_07_010 crossref_primary_10_1016_j_eclinm_2018_07_002 crossref_primary_10_1097_ACI_0b013e3283489ae5 crossref_primary_10_1177_20587384211015061 crossref_primary_10_1111_all_13715 crossref_primary_10_1016_j_waojou_2022_100680 crossref_primary_10_1097_ACI_0000000000000548 crossref_primary_10_1007_s11882_012_0324_x crossref_primary_10_1016_j_annder_2016_06_004 crossref_primary_10_1016_j_jaip_2014_07_015 crossref_primary_10_1097_ACI_0b013e32833f1ba6 crossref_primary_10_3389_fimmu_2017_00614 crossref_primary_10_1016_j_medleg_2012_04_001 crossref_primary_10_1016_j_jaip_2020_08_006 crossref_primary_10_3390_biomedicines10040759 crossref_primary_10_3389_fphar_2020_575437 crossref_primary_10_1016_j_anai_2012_01_012 crossref_primary_10_1016_j_jaci_2009_12_981 crossref_primary_10_1111_all_13603 crossref_primary_10_1186_s12948_018_0097_4 crossref_primary_10_1111_cea_12591 crossref_primary_10_36691_RJA661 crossref_primary_10_1111_cod_14372 crossref_primary_10_1111_all_14147 crossref_primary_10_1016_j_anai_2019_11_022 crossref_primary_10_1515_pthp_2018_0023 crossref_primary_10_4168_aair_2022_14_4_348 crossref_primary_10_1111_all_12886 crossref_primary_10_1089_jop_2011_0221 crossref_primary_10_1111_j_1398_9995_2012_02840_x crossref_primary_10_1016_j_jaci_2012_04_050 crossref_primary_10_1111_ced_13990 crossref_primary_10_1111_ced_13991 crossref_primary_10_12793_tcp_2021_29_e10 crossref_primary_10_1016_j_jaci_2012_04_051 crossref_primary_10_1016_j_jbi_2010_02_003 crossref_primary_10_1016_j_reval_2010_01_036 crossref_primary_10_1016_j_iccl_2014_03_004 crossref_primary_10_4168_aard_2014_2_5_315 crossref_primary_10_1016_j_ejrad_2025_111939 crossref_primary_10_1016_j_iac_2014_03_002 crossref_primary_10_1016_j_ejrex_2010_03_003 crossref_primary_10_1007_s00105_012_2372_5 crossref_primary_10_1016_j_jaip_2023_07_004 crossref_primary_10_5124_jkma_2012_55_8_779 crossref_primary_10_1016_j_anai_2014_07_016 crossref_primary_10_1016_j_lpm_2014_12_008 crossref_primary_10_1016_j_ejrad_2009_09_019 crossref_primary_10_1016_j_anai_2015_07_019 crossref_primary_10_1007_s00330_011_2200_9 crossref_primary_10_1016_j_anai_2013_09_023 crossref_primary_10_1111_j_1365_2125_2010_03764_x crossref_primary_10_4168_aard_2015_3_6_449 crossref_primary_10_1259_bjr_20180107 crossref_primary_10_1586_eci_11_14 crossref_primary_10_1002_cmmi_331 crossref_primary_10_1007_s40521_021_00287_x crossref_primary_10_1213_ANE_0000000000005443 crossref_primary_10_1016_j_jaci_2011_08_042 crossref_primary_10_1016_j_nefro_2021_05_008 crossref_primary_10_36691_RJA278 crossref_primary_10_5124_jkma_2020_63_3_155 crossref_primary_10_1007_s11882_014_0442_8 crossref_primary_10_1053_j_trap_2015_01_010 crossref_primary_10_1007_s10555_013_9447_3 crossref_primary_10_1016_j_reval_2015_01_039 crossref_primary_10_1002_ccd_24767 crossref_primary_10_1111_j_1398_9995_2008_01960_x crossref_primary_10_1016_j_iccl_2020_02_002 crossref_primary_10_1016_j_jaci_2011_08_043 crossref_primary_10_1016_j_jaip_2013_12_001 crossref_primary_10_1016_j_jaip_2018_01_014 crossref_primary_10_1111_all_14061 crossref_primary_10_1111_cod_13242 crossref_primary_10_1111_j_1365_2222_2009_03361_x crossref_primary_10_1016_j_jacr_2016_10_017 crossref_primary_10_1016_j_jaip_2018_06_030 crossref_primary_10_1259_bjr_83_991_633 crossref_primary_10_3390_diagnostics12071673 crossref_primary_10_1111_j_1600_0536_2010_01816_x crossref_primary_10_1111_all_12323 crossref_primary_10_1111_cea_12703 crossref_primary_10_36691_RJA626 crossref_primary_10_1016_j_jaci_2009_10_028 crossref_primary_10_1016_j_iac_2015_01_008 crossref_primary_10_3389_fvets_2020_00447 crossref_primary_10_1016_j_jaip_2017_03_016 crossref_primary_10_1016_j_jaip_2022_03_030 crossref_primary_10_1097_RMR_0000000000000109 crossref_primary_10_1016_j_jim_2020_112745 crossref_primary_10_1007_s11547_016_0646_1 crossref_primary_10_1016_j_jaip_2017_10_040 crossref_primary_10_1111_j_1398_9995_2009_02137_x crossref_primary_10_1016_j_anai_2019_12_030 crossref_primary_10_1259_bjr_23957418 crossref_primary_10_1586_1744666X_2013_828871 crossref_primary_10_1016_S0716_8640_11_70425_4 crossref_primary_10_1111_all_12214 crossref_primary_10_1177_0284185114568049 crossref_primary_10_3390_physiologia2030006 crossref_primary_10_1016_j_ejrad_2010_06_014 crossref_primary_10_1016_j_aller_2013_01_002 crossref_primary_10_1111_j_1365_2222_2010_03493_x crossref_primary_10_1007_s00330_019_06138_3 crossref_primary_10_1007_s40521_017_0130_8 |
Cites_doi | 10.1111/j.1398-9995.2005.00745.x 10.1016/j.tox.2004.12.020 10.1016/S0091-6749(99)70197-1 10.1007/s00330-002-1620-y 10.1111/j.1398-9995.1998.tb03832.x 10.1136/emj.13.2.114 10.1111/j.1398-9995.2001.00002.x-i1 10.1016/j.tox.2004.12.032 10.1016/j.jaci.2004.09.012 10.1034/j.1398-9995.2001.056003250.x 10.1148/radiol.2251011654 10.1016/S0091-6749(99)70439-2 10.1159/000096920 10.1034/j.1398-9995.1999.00247.x 10.1016/j.jaci.2007.02.007 10.1002/cmmi.63 10.1148/radiology.175.3.2343107 10.1111/j.1365-2222.2006.02532.x 10.1016/S0335-7457(01)00130-7 10.1002/pds.822 10.1111/j.0105-1873.2004.00367.x 10.1148/radiology.209.1.9769830 10.1034/j.1600-0536.2001.450601.x 10.7326/0003-4819-140-12-200406150-00009 10.1016/S0140-6736(77)91953-5 10.1007/s00330-006-0202-9 |
ContentType | Journal Article |
Copyright | 2009 The Authors. Journal compilation © 2009 Blackwell Munksgaard 2009 INIST-CNRS Journal compilation © 2009 Blackwell Munksgaard |
Copyright_xml | – notice: 2009 The Authors. Journal compilation © 2009 Blackwell Munksgaard – notice: 2009 INIST-CNRS – notice: Journal compilation © 2009 Blackwell Munksgaard |
CorporateAuthor | for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity |
CorporateAuthor_xml | – name: for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity – name: European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity |
DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7S9 L.6 7X8 |
DOI | 10.1111/j.1398-9995.2008.01832.x |
DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic AGRICOLA MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1398-9995 0108-1675 |
EndPage | 241 |
ExternalDocumentID | 1631373861 19178403 21059512 10_1111_j_1398_9995_2008_01832_x ALL1832 US201301584097 |
Genre | article Multicenter Study Journal Article |
GeographicLocations | Europe |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABJNI ABLJU ABOCM ABPTK ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FBQ FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ AHBTC AHEFC AITYG ALVPJ HGLYW OIG WIN AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION IQODW AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c5602-344f9f7bc1adb841817c43e3a1586be986fae3e24b8f2be8b9b845e7c4c237b83 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 1398-9995 |
IngestDate | Fri Jul 11 06:46:00 EDT 2025 Fri Jul 11 00:14:39 EDT 2025 Fri Jul 11 15:16:49 EDT 2025 Sun Jul 13 04:34:17 EDT 2025 Mon Jul 21 05:45:55 EDT 2025 Wed Apr 02 07:25:37 EDT 2025 Thu Apr 24 23:10:15 EDT 2025 Tue Jul 01 04:14:46 EDT 2025 Wed Jan 22 16:33:31 EST 2025 Wed Dec 27 19:15:19 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Human skin tests Immunopathology Immunology Dermatology Multicenter study Hypersensitivity Exploration Radioopaque marker Contrast media Iodine Skin test |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5602-344f9f7bc1adb841817c43e3a1586be986fae3e24b8f2be8b9b845e7c4c237b83 |
Notes | http://dx.doi.org/10.1111/j.1398-9995.2008.01832.x ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01832.x |
PMID | 19178403 |
PQID | 196894143 |
PQPubID | 34098 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_66860153 proquest_miscellaneous_46133520 proquest_miscellaneous_20401759 proquest_journals_196894143 pubmed_primary_19178403 pascalfrancis_primary_21059512 crossref_citationtrail_10_1111_j_1398_9995_2008_01832_x crossref_primary_10_1111_j_1398_9995_2008_01832_x wiley_primary_10_1111_j_1398_9995_2008_01832_x_ALL1832 fao_agris_US201301584097 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2009 |
PublicationDateYYYYMMDD | 2009-02-01 |
PublicationDate_xml | – month: 02 year: 2009 text: February 2009 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Denmark – name: Zurich |
PublicationTitle | Allergy |
PublicationTitleAlternate | Allergy |
PublicationYear | 2009 |
Publisher | Oxford, UK : Blackwell Publishing Ltd Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Oxford, UK : Blackwell Publishing Ltd – name: Blackwell Publishing Ltd – name: Blackwell |
References | 1993; 25 2008; 190 2000; 47 2006; 16 2002; 12 2005; 115 2004; 140 2006; 36 2007 1999; 103 2006; 1 2005; 60 2001; 45 1996; 13 2003; 12 2007; 214 2004; 50 2000; 18 2007; 119 2002; 42 2001; 6 2002; 225 1977; 1 1998; 209 2005; 209 1999; 54 1999; 31 2005; 15 2001; 56 2005; 17 1998; 53 1990; 175 Christiansen C (e_1_2_6_2_2) 2007 e_1_2_6_18_2 Christiansen C (e_1_2_6_11_2) 2002; 12 e_1_2_6_19_2 e_1_2_6_35_2 e_1_2_6_13_2 e_1_2_6_10_2 e_1_2_6_33_2 Brockow K (e_1_2_6_12_2) 1999; 31 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 Gomes ER (e_1_2_6_32_2) 2005; 17 e_1_2_6_20_2 Trcka J (e_1_2_6_30_2) 2008; 190 Guillen Toledo J (e_1_2_6_23_2) 2000; 47 Kanny G (e_1_2_6_34_2) 1993; 25 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 Hosoya T (e_1_2_6_25_2) 2000; 18 e_1_2_6_5_2 e_1_2_6_24_2 Mertes PM (e_1_2_6_31_2) 2005; 15 e_1_2_6_22_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 |
References_xml | – volume: 214 start-page: 89 year: 2007 end-page: 93 article-title: Recurrent flexural exanthema (SDRIF or baboon syndrome) after administration of two different iodinated radio contrast media publication-title: Dermatology – volume: 54 start-page: 999 year: 1999 end-page: 1003 article-title: Drug hypersensitivity: questionnaire publication-title: Allergy – volume: 13 start-page: 114 year: 1996 end-page: 115 article-title: Patients’ knowledge about their drug allergies publication-title: J Accid Emerg Med – volume: 15 start-page: 91 year: 2005 end-page: 101 article-title: Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice publication-title: J Investig Allergol Clin Immunol – volume: 140 start-page: 1001 year: 2004 end-page: 1006 article-title: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction publication-title: Ann Intern Med – volume: 16 start-page: 1570 year: 2006 end-page: 1579 article-title: A practical guide to diagnose lesser‐known immediate and delayed contrast media‐induced adverse cutaneous reactions publication-title: Eur Radiol – volume: 6 start-page: 250 year: 2001 end-page: 251 article-title: Allergy and contrast media publication-title: Allergy – volume: 225 start-page: 466 year: 2002 end-page: 470 article-title: Effective prophylactic protocol in delayed hypersensitivity to contrast media: report of a case involving lymphocyte transformation studies with different compounds publication-title: Radiology – volume: 50 start-page: 359 year: 2004 end-page: 366 article-title: Low negative predictive value of skin tests in investigating delayed reactions to radio‐contrast media publication-title: Contact Dermatitis – start-page: 140 year: 2007 end-page: 148 – volume: 1 start-page: 81 year: 2006 article-title: Immediate reactions following ICM injection: results of a 3‐year prospective multicenter survey publication-title: Contrast Med Mol Imaging – volume: 45 start-page: 321 year: 2001 end-page: 328 article-title: Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions publication-title: Contact Dermatitis – volume: 115 start-page: 179 year: 2005 end-page: 185 article-title: T cell‐mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests publication-title: J Allergy Clin Immunol – volume: 36 start-page: 1072 year: 2006 end-page: 1077 article-title: Diagnosis of iodinated contrast media hypersensitivity: results of a 6‐year period publication-title: Clin Exp Allergy – volume: 209 start-page: 189 year: 2005 end-page: 192 article-title: Contrast media hypersensitivity – scope of the problem publication-title: Toxicology – volume: 209 start-page: 185 year: 2005 end-page: 187 article-title: X‐ray contrast media – an overview publication-title: Toxicology – volume: 31 start-page: 49 year: 1999 end-page: 51 article-title: Positive skin tests in late reactions to radiographic contrast media publication-title: Allerg Immunol (Paris) – volume: 103 start-page: 1186 year: 1999 end-page: 1190 article-title: A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins publication-title: J Allergy Clin Immunol – volume: 119 start-page: 1529 year: 2007 end-page: 1536 article-title: Cross‐reactivity patterns of T cells specific for iodinated contrast media publication-title: J Allergy Clin Immunol – volume: 12 start-page: S94 issue: Suppl 4 year: 2002 end-page: 97 article-title: Macular exanthema appearing 5 days after X‐ray contrast medium administration publication-title: Eur Radiol – volume: 60 start-page: 150 year: 2005 end-page: 158 article-title: Management of hypersensitivity reactions to iodinated contrast media publication-title: Allergy – volume: 103 start-page: 918 year: 1999 end-page: 924 article-title: Natural evolution of skin test sensitivity in patients allergic to beta‐lactam antibiotics publication-title: J Allergy Clin Immunol – volume: 56 start-page: 813 year: 2001 end-page: 824 article-title: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force publication-title: Allergy – volume: 18 start-page: 39 year: 2000 end-page: 45 article-title: Delayed adverse reactions to iodinated contrast media and their risk factors publication-title: Radiat Med – volume: 17 start-page: 1 year: 2005 end-page: 10 article-title: The drug ambassador project. The diversity of diagnostic procedures for drug allergy around Europe publication-title: Allergy Clin Immunol Int J World Allergy Org – volume: 25 start-page: 425 year: 1993 end-page: 430 article-title: Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE‐mediated reaction publication-title: Allerg Immunol (Paris) – volume: 1 start-page: 466 year: 1977 end-page: 469 article-title: Incidence and severity of anaphylactoid reactions to colloid volume substitutes publication-title: Lancet – volume: 12 start-page: 195 year: 2003 end-page: 202 article-title: Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study publication-title: Pharmacoepidemiol Drug Saf – volume: 47 start-page: 22 year: 2000 end-page: 25 article-title: Anamnesis and skin test to prevent fatal reactions to iodinated contrast media publication-title: Rev Alerg Mex – volume: 53 start-page: 1133 year: 1998 end-page: 1140 article-title: Detection of IgE antibody to a radiocontrast medium publication-title: Allergy – volume: 42 start-page: 157 year: 2002 end-page: 162 article-title: Anaphylactic shock with ioxaglate during coronary angiography: Two cases publication-title: Rev Fr Allergol Immunol Clin – volume: 190 start-page: 666 year: 2008 end-page: 670 article-title: Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE‐mediated allergy? publication-title: Am J Radiol – volume: 209 start-page: 183 year: 1998 end-page: 190 article-title: Mechanisms of severe, immediate reactions to iodinated contrast material publication-title: Radiology – volume: 175 start-page: 621 year: 1990 end-page: 628 article-title: Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media publication-title: Radiology – ident: e_1_2_6_21_2 doi: 10.1111/j.1398-9995.2005.00745.x – ident: e_1_2_6_6_2 doi: 10.1016/j.tox.2004.12.020 – ident: e_1_2_6_26_2 doi: 10.1016/S0091-6749(99)70197-1 – volume: 12 start-page: S94 issue: 4 year: 2002 ident: e_1_2_6_11_2 article-title: Macular exanthema appearing 5 days after X‐ray contrast medium administration publication-title: Eur Radiol doi: 10.1007/s00330-002-1620-y – ident: e_1_2_6_29_2 doi: 10.1111/j.1398-9995.1998.tb03832.x – start-page: 140 volume-title: Drug hypersensitivity year: 2007 ident: e_1_2_6_2_2 – volume: 190 start-page: 666 year: 2008 ident: e_1_2_6_30_2 article-title: Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE‐mediated allergy? publication-title: Am J Radiol – ident: e_1_2_6_20_2 doi: 10.1136/emj.13.2.114 – ident: e_1_2_6_7_2 doi: 10.1111/j.1398-9995.2001.00002.x-i1 – ident: e_1_2_6_3_2 doi: 10.1016/j.tox.2004.12.032 – ident: e_1_2_6_10_2 doi: 10.1016/j.jaci.2004.09.012 – volume: 31 start-page: 49 year: 1999 ident: e_1_2_6_12_2 article-title: Positive skin tests in late reactions to radiographic contrast media publication-title: Allerg Immunol (Paris) – ident: e_1_2_6_35_2 doi: 10.1034/j.1398-9995.2001.056003250.x – ident: e_1_2_6_8_2 doi: 10.1148/radiol.2251011654 – volume: 47 start-page: 22 year: 2000 ident: e_1_2_6_23_2 article-title: Anamnesis and skin test to prevent fatal reactions to iodinated contrast media publication-title: Rev Alerg Mex – ident: e_1_2_6_22_2 doi: 10.1016/S0091-6749(99)70439-2 – volume: 17 start-page: 1 year: 2005 ident: e_1_2_6_32_2 article-title: The drug ambassador project. The diversity of diagnostic procedures for drug allergy around Europe publication-title: Allergy Clin Immunol Int J World Allergy Org – volume: 18 start-page: 39 year: 2000 ident: e_1_2_6_25_2 article-title: Delayed adverse reactions to iodinated contrast media and their risk factors publication-title: Radiat Med – ident: e_1_2_6_13_2 doi: 10.1159/000096920 – ident: e_1_2_6_17_2 doi: 10.1034/j.1398-9995.1999.00247.x – ident: e_1_2_6_27_2 doi: 10.1016/j.jaci.2007.02.007 – ident: e_1_2_6_15_2 doi: 10.1002/cmmi.63 – ident: e_1_2_6_24_2 doi: 10.1148/radiology.175.3.2343107 – ident: e_1_2_6_14_2 doi: 10.1111/j.1365-2222.2006.02532.x – ident: e_1_2_6_16_2 doi: 10.1016/S0335-7457(01)00130-7 – ident: e_1_2_6_4_2 doi: 10.1002/pds.822 – ident: e_1_2_6_9_2 doi: 10.1111/j.0105-1873.2004.00367.x – ident: e_1_2_6_28_2 doi: 10.1148/radiology.209.1.9769830 – ident: e_1_2_6_19_2 doi: 10.1034/j.1600-0536.2001.450601.x – volume: 15 start-page: 91 year: 2005 ident: e_1_2_6_31_2 article-title: Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_6_33_2 doi: 10.7326/0003-4819-140-12-200406150-00009 – volume: 25 start-page: 425 year: 1993 ident: e_1_2_6_34_2 article-title: Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE‐mediated reaction publication-title: Allerg Immunol (Paris) – ident: e_1_2_6_18_2 doi: 10.1016/S0140-6736(77)91953-5 – ident: e_1_2_6_5_2 doi: 10.1007/s00330-006-0202-9 |
SSID | ssj0007290 ssj0012798 ssj0068258 |
Score | 2.4278965 |
Snippet | Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity... Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the... Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the... Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the... Background:Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the... |
SourceID | proquest pubmed pascalfrancis crossref wiley fao |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 234 |
SubjectTerms | Adolescent Adult adverse effects Aged Aged, 80 and over Allergies Biological and medical sciences Child Contrast Media Contrast Media - adverse effects Cross Reactions Cross Reactions - immunology diagnosis Diagnostic tests diagnostic use Drug Hypersensitivity Drug Hypersensitivity - diagnosis Drug Hypersensitivity - etiology Drug Hypersensitivity - immunology etiology Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans hypersensitivity Immunology Iodine Iodine - adverse effects Iodine - immunology Male Medical imaging Medical sciences Middle Aged Prospective Studies Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Sensitivity and Specificity Skin Skin Tests Young Adult |
Title | Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1398-9995.2008.01832.x https://www.ncbi.nlm.nih.gov/pubmed/19178403 https://www.proquest.com/docview/196894143 https://www.proquest.com/docview/20401759 https://www.proquest.com/docview/46133520 https://www.proquest.com/docview/66860153 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB8SFb2goFB-4ZtWNndg5VoiqQoUDsFJvlu11CipK0CYrIU78B_4hv4Q3jndLUCtViFuk2Ek8mRm_sZ9nGHspAcqBM5Z5IPgmrWtyW6l5XuCrvZDCKxuzfb6rjhfyzWl5mvhPdBZmzA-xXXAjy4j-mgzcun5q5KKGsdZ1mSiRpJ0zwpNE3SJ89P4ik5RKyy2AE7mEkU9JPZc-aDJT3WxsR7xJ20N0zVjz4jJQOsW4cZI6usvON8MbuSnns_XgZv77X5kf_8_477E7Ccvyw1H57rMboX3Abr1Nu_UP2Zoqe_GB8ni0ZxyXKYlrz2n1l39CCLzqiUA_VrDgwK_xlEXPh45_7jCrAggveWTT237g8ZQL__XjJ7d8s4vAIyOSKKZhxWOu3EdscfT646vjPJV5yD3gVpELKZu6Uc7P7dJpCcihvBRB2HmpKxdqXTU2iFBIp5vCBe1qtCoDGvlCKKfFY7bTdm3YZbxRSh_4EvrlCIlaJzUgVYDPgRtdqiJjavNLjU850KkUxxfzRywEqRqSaqrQSVI13zI23_b8OuYBuUafXWiNsWdw12bxoaBNYoyJMoxlbH-iSttnFoR3AcIytrfRLZO8Sm_gLXUtgXAz9mJ7F-6A9nhsG7p1j_cjYFZlfXULWCedszu4ukVVaYTpJd7yZFTqixEjuMf3404VVfPaojCHJyd09fRfO-6x2-M-HhGJnrGdYbUOzwEHB7cfDf03j8FPvg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELWgSMAFKBQaCq0PXLPqJk7sHCtEtcC2B9qVerPsrFMQVYI2WQlx4h_4Q76EN453S1ArVRW3SLGTeDIzfmOP3zD2RgCUA2fMY0fwTRhbxSaX4zjBV5epSEtpPNvncT6ZiQ9n2VkoB0RnYXp-iPWCG1mG99dk4LQgPbTytIC1FkUWciJJPUcAlPeowLePrz5dcknJsOACQBELmPkwrefKJw3mqruVaShz0rQQXtVXvbgKlg5Rrp-mDh-zi9UA--yUr6NlZ0flj3-4H_-TBJ6wRwHO8oNe_zbZHVc_ZfePwob9M7ak4l68IyqP-pzjMvC4tpwWgPlnRMGLlnLo-yIWHBDWH7RoedfwLw0mVmDhOfcJ9abtuD_own___MUNX20kcJ8USVmmbsE9Xe4Wmx2-O307iUOlh7gE4kriVIiqqKQtx2ZulQDqkKVIXWrGmcqtK1ReGZe6RFhVJdYpW6BV5tCoTFJpVfqcbdRN7bYZr6RU-2UGFbMERo0VCqjKwe3Ak85lEjG5-qe6DDToVI3jQv8VDkGqmqQainSSVPX3iI3XPb_1VCA36LMNtdHmHB5bz04S2ifGmIhkLGK7A11aPzMhyAscFrGdlXLp4FhaDYepCgGQG7G99V14BNrmMbVrli3ej5hZZsX1LWCgdNRu__oWea4QqWd4y4teqy9HjPge3487udfNG4tCH0yndPXyth332IPJ6dFUT98ff9xhD_ttPcoresU2usXSvQY67Oyut_o_ei9T2Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgSBUXvqGh0PrANavdxImdY0VZFVgqBKzUm2VnnYKKkmqTlRAn_gP_kF_CG8e7JaiVKsQtUuwknsyM39jjN4y9EADlwBmL2BF8E8ZWscnlJE7w1WUq0lIaz_Z5nB_NxZuT7CTkP9FZmJ4fYrPgRpbh_TUZ-PmiGhp5WsBYiyILKZGknSPgyVsiHyvS8MMPF1RSMqy3AE_EAlY-zOq59EmDqepmZRpKnDQtZFf1RS8uQ6VDkOtnqelddrYeX5-ccjZadXZUfv-L-vH_COAeuxPALD_ote8-u-HqB2z7Xdiuf8hWVNqLd0TkUZ9yXAYW15bT8i__jBh42VIGfV_CggPA-mMWLe8a_qXBtAokvOA-nd60HffHXPivHz-54ettBO5TIinH1C25J8t9xObTV59eHsWhzkNcAm8lcSpEVVTSlhOzsEoAc8hSpC41k0zl1hUqr4xLXSKsqhLrlC3QKnNoVCaptCp9zLbqpnY7jFdSqnGZQcEsQVFjhQKmcnA68KMLmURMrn-pLgMJOtXi-Kr_CIYgVU1SDSU6Sar6W8Qmm57nPRHINfrsQGu0OYW_1vOPCe0SY0xEMRaxvYEqbZ6ZEOAFCovY7lq3dHArrYa7VIUAxI3Y_uYu_AFt8pjaNasW70fELLPi6hYwTzpoN766RZ4rxOkZ3vKkV-qLESO6x_fjTu5V89qi0AezGV09_deO-2z7_eFUz14fv91lt_s9PUoqesa2uuXKPQc07Oyet_nfSrBSkQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Skin+testing+in+patients+with+hypersensitivity+reactions+to+iodinated+contrast+media+%3A+a+European+multicenter+study&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=BROCKOW%2C+K&rft.au=ROMANO%2C+A&rft.au=RING%2C+J&rft.au=RODRIGUES+CERNADAS%2C+J&rft.date=2009-02-01&rft.pub=Blackwell&rft.issn=0105-4538&rft.volume=64&rft.issue=2&rft.spage=234&rft.epage=241&rft_id=info:doi/10.1111%2Fj.1398-9995.2008.01832.x&rft.externalDBID=n%2Fa&rft.externalDocID=21059512 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |